172 related articles for article (PubMed ID: 10533193)
1. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
3. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
[TBL] [Abstract][Full Text] [Related]
4. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
Fritzsche H
Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
[TBL] [Abstract][Full Text] [Related]
5. 99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management.
Sirisriro R; Podoloff DA; Patt YZ; Curley SA; Kasi LP; Bhadkamkar VA; Kim EE; Murray JL; Smith R; Haynie TP
Nucl Med Commun; 1996 Jul; 17(7):568-76. PubMed ID: 8843115
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
[TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
8. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods].
Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W
Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937
[TBL] [Abstract][Full Text] [Related]
9. 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results.
Baum RP; Hertel A; Lorenz M; Schwarz A; Encke A; Hör G
Nucl Med Commun; 1989 May; 10(5):345-52. PubMed ID: 2662074
[TBL] [Abstract][Full Text] [Related]
10. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
11. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
Bock E; Becker W; Scheele J; Wolf F
Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
[TBL] [Abstract][Full Text] [Related]
13. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
[TBL] [Abstract][Full Text] [Related]
15. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
[TBL] [Abstract][Full Text] [Related]
16. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26).
Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M
Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179
[TBL] [Abstract][Full Text] [Related]
18. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
20. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
